Peng Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Peng Tan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Anshan Shan
College of Animal Science and Technology, Northeast Agricultural University, Harbin, China
3 shared publications Changxuan Shao
Laboratory of Molecular Nutrition and Immunity. The Institute of Animal Nutrition, Northeast Agricultural University, Harbin 150030, P. R. China
3 shared publicationsYongjie Zhu
Laboratory of Molecular Nutrition and Immunity. The Institute of Animal Nutrition, Northeast Agricultural University, Harbin 150030, P. R. China
3 shared publicationsGuoyu Li
Laboratory of Molecular Nutrition and Immunity. The Institute of Animal Nutrition, Northeast Agricultural University, Harbin 150030, P. R. China
2 shared publicationsQiao Jian
Laboratory of Molecular Nutrition and Immunity. The Institute of Animal Nutrition, Northeast Agricultural University, Harbin 150030, P. R. China
2 shared publicationsZhenheng Lai
Laboratory of Molecular Nutrition and Immunity, The Institute of Animal Nutrition , Northeast Agricultural University , Harbin 150030 , China
2 shared publications
Latest Publications
- 24 July 2020
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (17) , 9421-9435
Rational Avoidance of Protease Cleavage Sites and Symmetrical End-Tagging Significantly Enhances the Stability and Therapeutic Potential of Antimicrobial Peptides
Antimicrobial peptides (AMPs) are expected to solve problem of antibiotic resistance due to their distinctive nonspecific membrane-disruptive mechanism. However, clinical application of AMPs has been precluded by their poor stability, although various complex chemical strategies have been employed to solve this problem, and this undoubtedly greatly increases the manufacturing cost. Herein, a series of novel peptides with high stability were developed based on protease-specific cleavage sites and symmetrical end-tagging. Among these peptides, II-I4-II exhibited the best antibacterial activity and the highest therapeutic index. More importantly, II-I4-II showed extremely high stability in the presence of various proteases, physiological salts and serum, and under acid, alkali and heat conditions, and it exhibited excellent therapeutic potential in vivo. Additionally, II-I4-II exhibited a membrane-disruptive mechanism and a low propensity to induce resistance. In general, these findings contribute to the design of AMPs with high stability, and might accelerate clinical application of AMPs.
- 24 July 2020
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (17) , 9421-9435
Rational Avoidance of Protease Cleavage Sites and Symmetrical End-Tagging Significantly Enhances the Stability and Therapeutic Potential of Antimicrobial Peptides
Antimicrobial peptides (AMPs) are expected to solve problem of antibiotic resistance due to their distinctive nonspecific membrane-disruptive mechanism. However, clinical application of AMPs has been precluded by their poor stability, although various complex chemical strategies have been employed to solve this problem, and this undoubtedly greatly increases the manufacturing cost. Herein, a series of novel peptides with high stability were developed based on protease-specific cleavage sites and symmetrical end-tagging. Among these peptides, II-I4-II exhibited the best antibacterial activity and the highest therapeutic index. More importantly, II-I4-II showed extremely high stability in the presence of various proteases, physiological salts and serum, and under acid, alkali and heat conditions, and it exhibited excellent therapeutic potential in vivo. Additionally, II-I4-II exhibited a membrane-disruptive mechanism and a low propensity to induce resistance. In general, these findings contribute to the design of AMPs with high stability, and might accelerate clinical application of AMPs.
- 30 December 2019
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (2) , 2129-2144
Design of Heptad Repeat Amphiphiles Based on Database Filtering and Structure–Function Relationships to Combat Drug-Resistant Fungi and Biofilms
Due to the emergence of reports of multidrug-resistant fungi, infections caused by multidrug-resistant fungi and biofilms are considered to be a global threat to human health due to the lack of effective broad-spectrum drugs. Here, we developed a series heptad repeat sequences based on an antimicrobial peptide database (APD) and structure–function relationships. Among the developed peptides, the target peptide ACR3 exhibited good activity against all fungi and bacteria tested, including fluconazole-resistant Candida albicans (C. albicans) and methicillin-resistant Staphylococcu saureus (S. aureus), while demonstrating relatively low toxicity and good salt tolerance. The peptide ACR3 inhibits the formation of C. albicans biofilms and has a therapeutic effect on mature biofilms in vitro and in vivo. Moreover, we did not observe any resistance of C. albicans and E. coli against the peptide ACR3. A series of assays and microscopy were used to analyze the antimicrobial mechanism. These results showed that the antimicrobial activity of the peptide ACR3 utilizes a multimodal mechanism that degrades the cell wall barrier, alters the cytoplasmic membrane electrical potential, and induces intracellular reactive oxygen species (ROS) production. In general, the peptide ACR3 is a potent antibacterial agent that shows great potential for use in biomedical coatings and healthcare formulas to combat the growing threat of fungal and bacterial infection.
- 30 December 2019
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (2) , 2129-2144
Design of Heptad Repeat Amphiphiles Based on Database Filtering and Structure–Function Relationships to Combat Drug-Resistant Fungi and Biofilms
Due to the emergence of reports of multidrug-resistant fungi, infections caused by multidrug-resistant fungi and biofilms are considered to be a global threat to human health due to the lack of effective broad-spectrum drugs. Here, we developed a series heptad repeat sequences based on an antimicrobial peptide database (APD) and structure–function relationships. Among the developed peptides, the target peptide ACR3 exhibited good activity against all fungi and bacteria tested, including fluconazole-resistant Candida albicans (C. albicans) and methicillin-resistant Staphylococcu saureus (S. aureus), while demonstrating relatively low toxicity and good salt tolerance. The peptide ACR3 inhibits the formation of C. albicans biofilms and has a therapeutic effect on mature biofilms in vitro and in vivo. Moreover, we did not observe any resistance of C. albicans and E. coli against the peptide ACR3. A series of assays and microscopy were used to analyze the antimicrobial mechanism. These results showed that the antimicrobial activity of the peptide ACR3 utilizes a multimodal mechanism that degrades the cell wall barrier, alters the cytoplasmic membrane electrical potential, and induces intracellular reactive oxygen species (ROS) production. In general, the peptide ACR3 is a potent antibacterial agent that shows great potential for use in biomedical coatings and healthcare formulas to combat the growing threat of fungal and bacterial infection.
- 19 December 2019
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 6 (1) , 398-414
Multiple Strategy Optimization of Specifically Targeted Antimicrobial Peptide Based on Structure–Activity Relationships to Enhance Bactericidal Efficiency
Unlike traditional broad-spectrum antibacterial agents, specifically targeted antimicrobial peptides (STAMPs) are difficult for bacteria to develop resistance to due to their unique membrane lytic mechanism. Additionally, STAMPs can maintain a normal ecological balance and provide long-term protection to the body. However, therapeutic applications of STAMPS are hindered by their weak activity and imperfect specificity, as well as lack of knowledge in understanding their structure–activity relationships. To investigate the effects of different parameters on the biological activities of STAMPs, a peptide sequence, WKKIWKDPGIKKWIK, was truncated, extended, and provided with an increased charge and altered amphipathicity. In addition, a novel template modification method for attaching a phage-displayed peptide, which recognized and bound to Escherichia coli (E. coli) cells, to the end of the sequence was introduced. Compared with the traditional template modification method, peptide 13, which contained a phage-displayed peptide at the C-terminus, exhibited superior narrow-spectrum antibacterial activity against E. coli compared to that of parental peptide 2, and the activity and specificity of peptide 13 were increased by 5.0 and 2.4 times, respectively. Additionally, peptide 13 showed low cytotoxicity and relatively desirable salt, serum, acid, alkaline and heat stability. In this study, peptide 13 specifically killed E. coli by causing cytoplasmic membrane rupture and cytosol leakage. In summary, these findings are useful for improving the activity and specificity of STAMPs and show that peptide 13 is able to combat the growing threat of E. coli infections.
- 19 December 2019
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 6 (1) , 398-414
Multiple Strategy Optimization of Specifically Targeted Antimicrobial Peptide Based on Structure–Activity Relationships to Enhance Bactericidal Efficiency
Unlike traditional broad-spectrum antibacterial agents, specifically targeted antimicrobial peptides (STAMPs) are difficult for bacteria to develop resistance to due to their unique membrane lytic mechanism. Additionally, STAMPs can maintain a normal ecological balance and provide long-term protection to the body. However, therapeutic applications of STAMPS are hindered by their weak activity and imperfect specificity, as well as lack of knowledge in understanding their structure–activity relationships. To investigate the effects of different parameters on the biological activities of STAMPs, a peptide sequence, WKKIWKDPGIKKWIK, was truncated, extended, and provided with an increased charge and altered amphipathicity. In addition, a novel template modification method for attaching a phage-displayed peptide, which recognized and bound to Escherichia coli (E. coli) cells, to the end of the sequence was introduced. Compared with the traditional template modification method, peptide 13, which contained a phage-displayed peptide at the C-terminus, exhibited superior narrow-spectrum antibacterial activity against E. coli compared to that of parental peptide 2, and the activity and specificity of peptide 13 were increased by 5.0 and 2.4 times, respectively. Additionally, peptide 13 showed low cytotoxicity and relatively desirable salt, serum, acid, alkaline and heat stability. In this study, peptide 13 specifically killed E. coli by causing cytoplasmic membrane rupture and cytosol leakage. In summary, these findings are useful for improving the activity and specificity of STAMPs and show that peptide 13 is able to combat the growing threat of E. coli infections.